Fetal Risk

Active Ingredient Index

1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · a · b · c · d · e · f · g · h · i · j · k · l · m · n · o · p · q · r · s · t · u · v · w · x · y · z

kanamycin (Ophthalmic)

D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but the potential benefits from the use of the drug in pregnant women may be acceptable despite its potential risks. This drug can cause fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus.

Group 5

Ausreichende Erfahrungen über die Anwendung beim Menschen liegen nicht vor.

Insufficient data are available on use in humans.

D

Drugs which have caused, are suspected to have caused or may be expected to cause, an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects. Accompanying texts should be consulted for further details.